SYNGAP1 and Intellectual disability: SYNGAP1-related nonsyndromic intellectual disability typically results from de novo heterozygous mutations (Hamdan et al., 2009) with ∼50% of SYNGAP1 patients exhibiting ASD symptoms (Vlaskamp et al., 2019).